While others have shown that CXCL1 is highly expressed within breast tumor and stromal cells, including immune cells and carcinoma-associated fibroblasts (CAF), the critical upstream pathways have not been clearly delineated in breast cancer [57,58,70]. This evidence concerns the gene CXCL1 and carcinoma.